SPOTLIGHT -
Irvine, CA-India-based Lupin Pharmaceuticals will promote gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) in the pediatric specialty area in the United States.
Hundreds of children to receive free eyecare, glasses
ROP: Treating and preventing blindness in preterm babies
NovaSight introducing CureSight to U.S. market
Managing a changing landscape of IRD pediatric cases
New genetic mutation behind childhood glaucoma identified
Visual outcomes after secondary IOL implantation in aphakic children